FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

BioMojo creates integrated software and hardware solutions to enhance human performance, decision-making, knowledge management, resilience, and ex ...

Kate Stratten leads Chapel Hill's IntraHealth International as it faces challenges in the wake of the Trump administration’s ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World’s Most Admired ...

According to the Museum of the City of New York, a garment worker in 1905 was expected to sew at a rate twice that of her 1900 counterpart. The factories had scant safety or fire protection, mandated ...

Finance Minister K.N. Balagopal will present the Kerala Budget for the 2025-26 fiscal in the State Legislative Assembly.

Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a pioneering clinical trial of its gene-edited xenotransplantation kidney, named UKidney, ...

The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.

In August, the Research Triangle Park-based company Pathalys Pharma secured $105 million in Series B funding to develop its kidney disease treatments. And last February, the Chapel Hill asthma ...

As spring approaches and January recedes into the distance, Britons will be trying to keep up the health kicks that began at ...